Exagen Inc. balance sheet

At the end of fiscal 2025, Exagen Inc. had total assets of $58.0m, total liabilities of $40.6m and shareholders' equity of $17.4m. It held $32.2m in cash against $22.9m of debt: net cash of $9.3m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Exagen Inc.: balance sheet, annual
Fiscal year	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Cash and equivalents	13	72	57	99	62	36	22	32	25
Receivables	6	6	9	10	6	7	8	11	12
Total current assets	21	81	71	113	73	48	36	49	43
Goodwill	6	6	6	6	0	—	—	—	—
Total assets	29	88	78	123	86	57	45	58	52
Accounts payable	1	1	3	2	3	3	4	4	4
Deferred revenue (current)	—	—	—	—	—	—	1	1	1
Total current liabilities	9	6	9	9	10	12	14	14	13
Short-term debt	—	—	—	0	0	0	0	1	1
Long-term debt	25	26	27	27	29	19	20	22	22
Total debt	25	26	27	27	29	19	20	23	23
Total liabilities	36	33	37	39	44	34	35	41	40
Shareholders' equity	−112	56	42	85	42	23	10	17	12
Non-controlling interests and other (assets − liabilities − equity)	105	—	—	—	—	—	—	—	—
Net debt (negative = net cash)	11	−46	−31	−72	−33	−17	−2	−9	−2
Shares outstanding	—	—	13m	16m	17m	17m	18m	23m	24m

US$ millions unless shown otherwise. Fiscal quarters.

Exagen Inc.: balance sheet, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Receivables	9	8	15	14	11	11	16	12
Total current assets	36	36	33	51	53	49	44	43
Total assets	44	45	40	59	63	58	52	52
Accounts payable	1	4	5	3	4	4	4	4
Deferred revenue (current)	—	1	1	1	1	1	1	1
Total current liabilities	9	14	14	10	13	14	13	13
Short-term debt	0	0	3	1	1	1	1	1
Long-term debt	20	20	18	22	22	22	22	22
Total debt	20	20	21	23	23	23	23	23
Total liabilities	31	35	34	38	45	41	38	40
Shareholders' equity	13	10	6	21	18	17	14	12
Shares outstanding	18m	18m	18m	22m	23m	23m	24m	24m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: PSNL vs XGN BNR vs XGN CDXS vs XGN

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Exagen Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Exagen Inc.